Screening and management of pulmonary arterial hypertension in systemic sclerosis
Systemic sclerosis-associated pulmonary hypertension (SSc-PH) and pulmonary arterial (PA) hypertension (SSc-PAH) are well-recognized manifestations. SSc-PH is a hemodynamic observation, and it is important to identify underlying etiology. SSc patients commonly have mixed etiology for SSc-PH due to i...
Saved in:
Main Authors: | Vivek Nagaraja, Dinesh Khanna |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=6;spage=204;epage=210;aulast=Nagaraja |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of patients with pulmonary arterial hypertension against systemic sclerodermia (part 2).
by: O. O. Khaniukov, et al.
Published: (2019-01-01) -
Management of patients with pulmonary arterial hypertension against of systemic sclerodermia (part 1).
by: Ye. D. Yehudina, et al.
Published: (2018-11-01) -
Multimodal Screening for Pulmonary Arterial Hypertension in Systemic Scleroderma: Current Methods and Future Directions
by: Ioan Teodor Dragoi, et al.
Published: (2024-12-01) -
New therapies in pulmonary arterial hypertension: Recent insights
by: Giulia Guglielmi, et al.
Published: (2025-03-01) -
Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland
by: Markku Pentikäinen, et al.
Published: (2024-12-01)